Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Larry Robbins Keeps Buying Shares of Tenet Healthcare Corp. (THC)

Larry RobbinsGlenview Capital has acquired more shares of Tenet Healthcare Corp. (NYSE:THC). In a Form 4 filed with the U.S. Securities and Exchange Commission, Glenview Capital disclosed purchases of 697,917 shares of the company at prices ranging from $54.00 to $54.91. Following the transactions, the hedge fund managed by Larry Robbins owns 15.49 million shares of Tenet Healthcare. This is the second acquisition of the company’s stock, disclosed by Glenview in the last couple of months. At the end of June, the investor bought 979,500 shares after the Supreme Court ruled in favor of the Affordable Care Act.


Glenview Capital Management is a New York-based hedge fund established by Larry Robbins in 2001. The hedge fund is well-known for its impressive returns generated under the leadership of Larry Robbins since the fund’s inception. He is the stock picker in charge at the firm and seeks for investment opportunities by analyzing the following four aspects: economic growth, liquidity, low valuations and excess cash balances. Glenview Capital generated an annualized return of 14.2% for a decade since the fund’s inception. Moreover, Glenview Capital’s flagship fund, Glenview Funds, has returned 301% over the same period of ten years, compared to the 15% return generated by S&P 500. The hedge fund primarily invests in the healthcare, industrial, financial, services and technology sectors. According to its most recent 13F with the SEC, Glenview Capital manages an equity portfolio with a value of $21.90 billion as of March 31, 2015.

Larry Robbins
Larry Robbins
Glenview Capital

But why do we track the hedge fund activities? From one point of view we can argue that hedge funds have consistently underperformed when it comes to net returns over the last three years, compared to the S&P 500. But that doesn’t mean that we should completely neglect the hedge funds’ activity. Our research has indicated that a specific group hedge funds’ long positions actually beat the market. In our back-tests covering the 1999-2012 period, hedge funds’ top small cap stocks edged the market by double digits annually. The 15 most popular small cap stock picks among hedge funds also beat the S&P 500 ETF (SPY) by around 66 percentage points over the 35-month period beginning with September 2012 (read more details here).

Tenet Healthcare Corp. (NYSE:THC) is a diversified healthcare services company that operates general acute care hospitals, short-stay surgical hospitals and outpatient centers through its subsidiaries, partnerships and joint ventures. Moreover, one of the company’s subsidiaries, Conifer Health Solutions, provides technology-enabled performance improvement and health management solutions to hospitals, health systems, integrated delivery networks (IDN), among others. The shares of Tenet have gained 5% since the beginning of the year, despite losing some ground since mid-July.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.